TANZEUM PROREDI Trademark

Trademark Overview


On Friday, January 20, 2017, a trademark application was filed for TANZEUM PROREDI with the United States Patent and Trademark Office. The USPTO has given the TANZEUM PROREDI trademark a serial number of 87308560. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 11, 2017. This trademark is owned by Glaxo Group Limited. The TANZEUM PROREDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances and auto injector devices filled with pharmaceutical preparations for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances and auto injector devices filled with pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
tanzeum proredi

General Information


Serial Number87308560
Word MarkTANZEUM PROREDI
Filing DateFriday, January 20, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 11, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances and auto injector devices filled with pharmaceutical preparations for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances and auto injector devices filled with pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 26, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, December 11, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 11, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 9, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 2, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 30, 2017ASSIGNED TO EXAMINER
Thursday, January 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 24, 2017NEW APPLICATION ENTERED IN TRAM